MyAverix Finance
US · Healthcare
Genetic Technologies Ltd (GENE)
Diagnostics & Research
Genetic Technologies Ltd (GENE) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-30, reported market cap is $3.71M, P/E ratio is 18.00, net margin is -124.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GENE
Genetic Technologies Ltd (GENE) — FAQ
What is Genetic Technologies Ltd's market cap?
Genetic Technologies Ltd (GENE) has a reported market cap of $3.71M (data as of 2026-03-30).
What is GENE's P/E ratio?
The price-to-earnings (P/E) ratio for Genetic Technologies Ltd (GENE) is 18.00 (data as of 2026-03-30).
Does Genetic Technologies Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Genetic Technologies Ltd (GENE). Check the MyAverix Finance app for the latest dividend data.
What sector is Genetic Technologies Ltd in?
Genetic Technologies Ltd (GENE) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is GENE listed on?
GENE is listed on US.
What is Genetic Technologies Ltd's net margin?
Genetic Technologies Ltd (GENE) reports a net margin of -124.2% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.